PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN
Abstract
Authors
T Fukuda T Shiroiwa T Takeuchi K Shimozuma Y Ohashi
T Fukuda T Shiroiwa T Takeuchi K Shimozuma Y Ohashi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now